KVP Capital Advisors »

Design Therapeutics shares owned by KVP Capital Advisors

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by KVP Capital Advisors from 13F filings

Historical chart of KVP Capital Advisors investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by KVP Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by KVP Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.7M 185k 14.47

More positions owned by KVP Capital Advisors

Praxis Precision Medicines I Com New (PRAX)
Aadi Bioscience (WHWK)
Erasca (ERAS)
Trevi Therapeutics (TRVI)
Sutro Biopharma Com Shs (STRO)
Tango Therapeutics (TNGX)
Mbx Biosciences (MBX)
Protagonist Therapeutics (PTGX)
Edgewise Therapeutics (EWTX)
Tandem Diabetes Care Com New (TNDM)
Disc Medicine (IRON)
Savara (SVRA)
Arrivent Biopharma (AVBP)
Insmed Com Par $.01 (INSM)
Achieve Life Sciences (ACHV)

View all positions for KVP Capital Advisors

Top funds holding Design Therapeutics

Sr One Capital Management
Logos Global Management
Baker Bros. Advisors
Driehaus Capital Management
BlackRock
Caption Management
Point72 Asset Management
Trails Edge Capital Partners
Frazier Life Sciences Management
Vivo Capital
Vanguard Capital Management
Almitas Capital
Geode Capital Management
Sofinnova Ventures
FMR

View all funds holding Design Therapeutics